Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 47 (1) , 103-109
- https://doi.org/10.1016/j.lungcan.2004.06.004
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trialLung Cancer, 1999
- Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.Journal of Clinical Oncology, 1998
- Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)Lung Cancer, 1997
- Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.Journal of Clinical Oncology, 1995
- A phase ii trial of combined chemotherapy and surgery in stage iiia non-small cell lung cancerLung Cancer, 1995
- Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patientsThe Annals of Thoracic Surgery, 1993
- Randomized trial of neoadjuvant therapy for lung cancer: Interim analysisThe Annals of Thoracic Surgery, 1992
- Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology groupCancer, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958